These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 6650978)

  • 1. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
    Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
    Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
    Santin M; Dorca J; Alcaide F; Gonzalez L; Casas S; Lopez M; Guerra MR
    Eur Respir J; 2009 Jan; 33(1):148-52. PubMed ID: 19118226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy.
    Sauret J; Hernández-Flix S; Castro E; Hernández L; Ausina V; Coll P
    Tuber Lung Dis; 1995 Apr; 76(2):104-8. PubMed ID: 7780090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
    Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
    Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex.
    Ahn CH; Ahn SS; Anderson RA; Murphy DT; Mammo A
    Am Rev Respir Dis; 1986 Sep; 134(3):438-41. PubMed ID: 3530069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Short-term initial chemotherapy with isoniazid, rifampin and ethambutol (streptomycin) in biphasic (3+6) administration, from the intermittent (2/7) beginning. Results after 2 years (cooperative experiment)].
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(2):79-90. PubMed ID: 195328
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
    Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Infection Caused by Mycobacterium shinjukuense.
    Oshima K; Yokouchi H; Minemura H; Saito J; Tanino Y; Munakata M
    Ann Am Thorac Soc; 2015 Jun; 12(6):958-9. PubMed ID: 26075560
    [No Abstract]   [Full Text] [Related]  

  • 14. [Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen].
    Bouslama A; Hedhiri H; Marzouki M; Jerray M; Djenayah F
    Bull Int Union Tuberc; 1985; 60(1-2):29-30. PubMed ID: 4074969
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability].
    Wada M; Yoshiyama T; Ogata H; Ito K; Mizutani S; Sugita H
    Kekkaku; 1999 Apr; 74(4):353-60. PubMed ID: 10355221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampin-resistant Mycobacterium kansasii.
    Wallace RJ; Dunbar D; Brown BA; Onyi G; Dunlap R; Ahn CH; Murphy DT
    Clin Infect Dis; 1994 May; 18(5):736-43. PubMed ID: 8075262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensive chemotherapy of pulmonary tuberculosis].
    Shesterina MV; Gavrilenko VS; Tarasova EF; Sokolova GV; Tregubov IuG
    Probl Tuberk; 1980 Jul; (7):20-22. PubMed ID: 6997865
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current short-term chemotherapy of tuberculosis. Fundamentals, assumptions, drug combinations, plan of treatment and prospects].
    Radenbach KL
    Internist (Berl); 1978 Dec; 19(12):672-9. PubMed ID: 370048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.